{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T14:59:23Z","timestamp":1771167563037,"version":"3.50.1"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"15","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Activation of gonadotropin-releasing hormone (GnRH) receptors inhibits proliferation of transformed cells derived from reproductive tissues and in transfected cell lines. Hence, GnRH receptors represent a therapeutic target for direct action of GnRH analogues on certain proliferating cells. However, more cell biological data are required to develop this particular application of GnRH analogues. Therefore, we compared the effects of GnRH receptor activation in transfected HEK293 cells (HEK293[SCL60]) with transfected human ovarian cancer cell lines SKOV3 and EFO21, human hepatoblastoma HepG2 cells, and rat neuroblastoma B35 cells. Marked differences in receptor levels, magnitude of inositol phosphate generation, and dynamics of inositol phosphate turnover occurred in the different cells. Activation of GnRH receptors, expressed at high or moderate levels, inhibited the growth of HEK293[SCL60] and B35 cells, respectively. Western blotting detected markers of apoptosis [cleaved poly(ADP-ribose) polymerase, caspase-9] in HEK293[SCL60] and B35 following treatment with 100 nmol\/L d-Trp6-GnRH-I. Cell growth inhibition was partially or completely rescued with inhibitor Q-VD-OPh or Ro32-0432. Low levels of GnRH receptor expression in transfected SKOV3, EFO21, or HepG2 activated intracellular signaling but did not induce apoptosis or significantly affect cell proliferation. Tumor xenografts prepared from HEK293[SCL60] regressed during treatment with d-Trp6-GnRH-I and growth of xenografts derived from transfected B35 was slowed. SKOV3 xenografts were not growth inhibited. Therefore, differences in levels of GnRH receptor and signaling differentially affect the apoptotic machinery within cell lines and contribute to the cell type\u2013specific effects of GnRH on growth. Further studies should exploit the growth-inhibitory potential of GnRH receptor activation in abnormal cells in diseased human tissues. [Cancer Res 2008;68(15):6331\u201340]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-0197","type":"journal-article","created":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T17:58:13Z","timestamp":1217613493000},"page":"6331-6340","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Gonadotropin-Releasing Hormone Receptor Levels and Cell Context Affect Tumor Cell Responses to Agonist<i>In vitro<\/i>and<i>In vivo<\/i>"],"prefix":"10.1158","volume":"68","author":[{"given":"Kevin","family":"Morgan","sequence":"first","affiliation":[{"name":"1Medical Research Council Human Reproductive Sciences Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan J.","family":"Stewart","sequence":"additional","affiliation":[{"name":"1Medical Research Council Human Reproductive Sciences Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Miller","sequence":"additional","affiliation":[{"name":"1Medical Research Council Human Reproductive Sciences Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Mullen","sequence":"additional","affiliation":[{"name":"2Edinburgh Breakthrough Research Unit, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morwenna","family":"Muir","sequence":"additional","affiliation":[{"name":"2Edinburgh Breakthrough Research Unit, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Dodds","sequence":"additional","affiliation":[{"name":"2Edinburgh Breakthrough Research Unit, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Medda","sequence":"additional","affiliation":[{"name":"1Medical Research Council Human Reproductive Sciences Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Harrison","sequence":"additional","affiliation":[{"name":"2Edinburgh Breakthrough Research Unit, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Langdon","sequence":"additional","affiliation":[{"name":"2Edinburgh Breakthrough Research Unit, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Millar","sequence":"additional","affiliation":[{"name":"1Medical Research Council Human Reproductive Sciences Unit and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2008,8,1]]},"reference":[{"key":"2022061700402376900_B1","doi-asserted-by":"crossref","unstructured":"Redding TW, Schally AV. Inhibition of prostate tumor growth in two rat models by chronic administration of d-Trp6 analogue of luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A\u20081981; 78: 6509\u201312.","DOI":"10.1073\/pnas.78.10.6509"},{"key":"2022061700402376900_B2","doi-asserted-by":"crossref","unstructured":"Duffaud F, van der Burg ME, Namer M, et al. d-TRP-6-LHRH (triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study. Anticancer Drugs\u20082001; 12: 159\u201362.","DOI":"10.1097\/00001813-200102000-00010"},{"key":"2022061700402376900_B3","doi-asserted-by":"crossref","unstructured":"Hasan J, Ton N, Mullamitha S, et al. Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer. Br J Cancer\u20082005; 93: 647\u201351.","DOI":"10.1038\/sj.bjc.6602752"},{"key":"2022061700402376900_B4","doi-asserted-by":"crossref","unstructured":"Lhomme C, Vennin P, Callet N, et al. A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation study. Gynecol Oncol\u20081999; 75: 87\u201393.","DOI":"10.1006\/gyno.1999.5538"},{"key":"2022061700402376900_B5","doi-asserted-by":"crossref","unstructured":"Cuzick J, Ambroisine L, Davidson N, et al. LHRH-agonists in Early Breast Cancer Overview group. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet\u20082007; 369: 1711\u201323.","DOI":"10.1016\/S0140-6736(07)60778-8"},{"key":"2022061700402376900_B6","doi-asserted-by":"crossref","unstructured":"Adjuvant Breast Cancer Trials Collaborative Group. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. J Natl Cancer Inst\u20082007; 99: 516\u201325.","DOI":"10.1093\/jnci\/djk109"},{"key":"2022061700402376900_B7","doi-asserted-by":"crossref","unstructured":"Boccardo F, Decensi A, Guarneri D, et al. Long-acting (depot) d-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial. Am J Clin Oncol\u20081988; 11 Suppl 2: S129\u201331.","DOI":"10.1097\/00000421-198801102-00033"},{"key":"2022061700402376900_B8","doi-asserted-by":"crossref","unstructured":"Eidne KA, Flanagan CA, Millar RP. Gonadotropin-releasing hormone binding sites in human breast carcinoma. Science\u20081985; 229: 989\u201391.","DOI":"10.1126\/science.2992093"},{"key":"2022061700402376900_B9","doi-asserted-by":"crossref","unstructured":"Blankenstein MA, Henkelman MS, Klijn JG. Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol\u20081985; 21: 1493\u20139.","DOI":"10.1016\/0277-5379(85)90244-5"},{"key":"2022061700402376900_B10","unstructured":"Sica G, Iacopino F, Marini L, Robustelli della Cuna G. Antiproliferative effect of leuprorelin acetate, alone or combined with tamoxifen or medroxyprogesterone acetate, on human breast cancer cell lines. Clin Ther\u20081991; 14 Suppl A: 87\u201396."},{"key":"2022061700402376900_B11","doi-asserted-by":"crossref","unstructured":"Limonta P, Dondi D, Moretti RM, Maggi R, Motta M. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP. J Clin Endocrinol Metab\u20081992; 75: 207\u201312.","DOI":"10.1210\/jcem.75.1.1320049"},{"key":"2022061700402376900_B12","unstructured":"Emons G, Ortmann O, Becker M, et al. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res\u20081993; 53: 5439\u201346."},{"key":"2022061700402376900_B13","doi-asserted-by":"crossref","unstructured":"Yano T, Pinski J, Radulovic S, Schally AV. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A\u20081994; 91: 1701\u20135.","DOI":"10.1073\/pnas.91.5.1701"},{"key":"2022061700402376900_B14","unstructured":"Kimura A, Ohmichi M, Kurachi H, et al. Role of mitogen-activated protein kinase\/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line. Cancer Res\u20081999; 59: 5133\u201342."},{"key":"2022061700402376900_B15","doi-asserted-by":"crossref","unstructured":"Ravenna L, Salvatori L, Morrone S, et al. Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP. J Androl\u20082000; 21: 549\u201357.","DOI":"10.1002\/j.1939-4640.2000.tb02120.x"},{"key":"2022061700402376900_B16","doi-asserted-by":"crossref","unstructured":"Noci I, Coronnello M, Borri P, et al. Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro. Cancer Lett\u20082000; 150: 71\u20138.","DOI":"10.1016\/S0304-3835(99)00374-2"},{"key":"2022061700402376900_B17","doi-asserted-by":"crossref","unstructured":"Kang SK, Choi KC, Cheng KW, Nathwani PS, Auersperg N, Leung PC. Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium. Endocrinology\u20082000; 141: 72\u201380.","DOI":"10.1210\/endo.141.1.7250"},{"key":"2022061700402376900_B18","unstructured":"Slotman BJ, Poels LG, Rao BR. A direct LHRH-agonist action on cancer cells is unlikely to be the cause of response to LHRH-agonist treatment. Anticancer Res\u20081989; 9: 77\u201380."},{"key":"2022061700402376900_B19","doi-asserted-by":"crossref","unstructured":"Pati D, Habibi HR. Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones. Endocrinology\u20081995; 136: 75\u201384.","DOI":"10.1210\/endo.136.1.7828560"},{"key":"2022061700402376900_B20","doi-asserted-by":"crossref","unstructured":"Moretti RM, Montagnani Marelli M, Van Groeninghen JC, Limonta P. Locally expressed LHRH receptors mediate the oncostatic and antimetastatic activity of LHRH agonists on melanoma cells. J Clin Endocrinol Metab\u20082002; 87: 3791\u20137.","DOI":"10.1210\/jcem.87.8.8755"},{"key":"2022061700402376900_B21","doi-asserted-by":"crossref","unstructured":"Peterson CM, Jolles CJ, Carrell DT, et al. GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transience. Gynecol Oncol\u20081994; 52: 26\u201330.","DOI":"10.1006\/gyno.1994.1006"},{"key":"2022061700402376900_B22","doi-asserted-by":"crossref","unstructured":"Kang SK, Choi KC, Tai CJ, Auersperg N, Leung PC. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells. Endocrinology\u20082001; 142: 580\u20138.","DOI":"10.1210\/endo.142.2.7982"},{"key":"2022061700402376900_B23","doi-asserted-by":"crossref","unstructured":"Imai A, Takagi H, Horibe S, Fuseya T, Tamaya T. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors. J Clin Endocrinol Metab\u20081996; 81: 3249\u201353.","DOI":"10.1210\/jcem.81.9.8784077"},{"key":"2022061700402376900_B24","doi-asserted-by":"crossref","unstructured":"Grundker C, Volker P, Emons G. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein \u03b1(I)-mediated activation of phosphotyrosine phosphatase. Endocrinology\u20082001; 142: 2369\u201380.","DOI":"10.1210\/endo.142.6.8190"},{"key":"2022061700402376900_B25","doi-asserted-by":"crossref","unstructured":"Gunthert AR, Grundker C, Hollmann K, Emons G. Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells. Biochem Biophys Res Commun\u20082002; 294: 11\u20135.","DOI":"10.1016\/S0006-291X(02)00427-8"},{"key":"2022061700402376900_B26","doi-asserted-by":"crossref","unstructured":"Miles LE, Hanyaloglu AC, Dromey JR, Pfleger KD, Eidne KA. Gonadotropin-releasing hormone receptor-mediated growth suppression of immortalized L\u03b2T2 gonadotrope and stable HEK293 cell lines. Endocrinology\u20082004; 145: 194\u2013204.","DOI":"10.1210\/en.2003-0551"},{"key":"2022061700402376900_B27","doi-asserted-by":"crossref","unstructured":"Kraus S, Levy G, Hanoch T, Naor Z, Seger R. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, extracellular signal-regulated kinase pathways. Cancer Res\u20082004; 64: 5736\u201344.","DOI":"10.1158\/0008-5472.CAN-04-1156"},{"key":"2022061700402376900_B28","doi-asserted-by":"crossref","unstructured":"Maudsley S, Davidson L, Pawson AJ, Chan R, de Maturana RL, Millar RP. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a G\u03b1i-coupling state of the type I GnRH receptor. Cancer Res\u20082004; 64: 7533\u201344.","DOI":"10.1158\/0008-5472.CAN-04-1360"},{"key":"2022061700402376900_B29","doi-asserted-by":"crossref","unstructured":"Kim K-Y, Choi K-C, Park S-H, Chou C-S, Auersperg N, Leung PCK. Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells. J Clin Endocrinol Metab\u20082004; 89: 3020\u20136.","DOI":"10.1210\/jc.2003-031871"},{"key":"2022061700402376900_B30","doi-asserted-by":"crossref","unstructured":"Kim KY, Choi KC, Park SH, Auersperg N, Leung PC. Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation. J Clin Endocrinol Metab\u20082005; 90: 1670\u20137.","DOI":"10.1210\/jc.2004-1636"},{"key":"2022061700402376900_B31","doi-asserted-by":"crossref","unstructured":"Kim KY, Choi KC, Auersperg N, Leung PC. Mechanism of gonadotropin-releasing hormone (GnRH)-I and-II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway. Endocr Relat Cancer\u20082006; 13: 211\u201320.","DOI":"10.1677\/erc.1.01033"},{"key":"2022061700402376900_B32","doi-asserted-by":"crossref","unstructured":"Lo\u0301pez de Maturana R, Pawson AJ, Lu ZL, et al. GnRH analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced-selective-signalling. Mol Endocrinol. In press 2008.","DOI":"10.1210\/me.2006-0537"},{"key":"2022061700402376900_B33","doi-asserted-by":"crossref","unstructured":"Everest HM, Hislop JN, Harding T, et al. Signaling and antiproliferative effects mediated by GnRH receptors after expression in breast cancer cells using recombinant adenovirus. Endocrinology\u20082001; 142: 4663\u201372.","DOI":"10.1210\/endo.142.11.8503"},{"key":"2022061700402376900_B34","doi-asserted-by":"crossref","unstructured":"Franklin J, Hislop J, Flynn A, McArdle CA. Signalling and anti-proliferative effects mediated by gonadotrophin-releasing hormone receptors after expression in prostate cancer cells using recombinant adenovirus. J Endocrinol\u20082003; 176: 275\u201384.","DOI":"10.1677\/joe.0.1760275"},{"key":"2022061700402376900_B35","doi-asserted-by":"crossref","unstructured":"Shaw G, Morse S, Ararat M, Graham FL. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J\u20082002; 16: 869\u201371.","DOI":"10.1096\/fj.01-0995fje"},{"key":"2022061700402376900_B36","doi-asserted-by":"crossref","unstructured":"Otey CA, Boukhelifa M, Maness P. B35 neuroblastoma cells: an easily transfected, cultured cell model of central nervous system neurons. Methods Cell Biol\u20082003; 71: 287\u2013304.","DOI":"10.1016\/S0091-679X(03)01013-6"},{"key":"2022061700402376900_B37","doi-asserted-by":"crossref","unstructured":"Hua W, Christianson T, Rougeot C, Rochefort H, Clinton GM. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J Steroid Biochem Mol Biol\u20081995; 55: 279\u201389.","DOI":"10.1016\/0960-0760(95)00187-5"},{"key":"2022061700402376900_B38","doi-asserted-by":"crossref","unstructured":"Schwartz AL, Fridovich SE, Knowles BB, Lodish HF. Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem\u20081981; 256: 8878\u201381.","DOI":"10.1016\/S0021-9258(19)52477-2"},{"key":"2022061700402376900_B39","unstructured":"Simon WE, Albrecht M, Ha\u0308nsel M, Dietel M, Ho\u0308lzel F. Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst\u20081983; 70: 839\u201345."},{"key":"2022061700402376900_B40","doi-asserted-by":"crossref","unstructured":"Anderson L, McGregor A, Cook JV, Chilvers E, Eidne KA. Rapid desensitization of GnRH-stimulated intracellular signalling events in \u03b1T3-1 and HEK-293 cells expressing the GnRH receptor. Endocrinology\u20081995; 136: 5228\u201331.","DOI":"10.1210\/endo.136.11.7588262"},{"key":"2022061700402376900_B41","doi-asserted-by":"crossref","unstructured":"Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst\u20081990; 82: 1107\u201312.","DOI":"10.1093\/jnci\/82.13.1107"},{"key":"2022061700402376900_B42","doi-asserted-by":"crossref","unstructured":"Janovick JA, Knollman PE, Brothers SP, Ayala-Yanez R, Aziz AS, Conn PM. Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy. J Biol Chem\u20082006; 281: 8417\u201325.","DOI":"10.1074\/jbc.M510601200"},{"key":"2022061700402376900_B43","doi-asserted-by":"crossref","unstructured":"Naor Z, Benard O, Seger R. Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab\u20082000; 11: 91\u20139.","DOI":"10.1016\/S1043-2760(99)00232-5"},{"key":"2022061700402376900_B44","doi-asserted-by":"crossref","unstructured":"Brehmer D, Godl K, Zech B, Wissing J, Daub H. 2004 Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors. Mol Cell Proteomics\u20082004; 3: 490\u2013500.","DOI":"10.1074\/mcp.M300139-MCP200"},{"key":"2022061700402376900_B45","doi-asserted-by":"crossref","unstructured":"Jezyk MR, Snyder JT, Gershberg S, Worthylake DK, Harden TK, Sondek J. Crystal structure of Rac1 bound to its effector phospholipase C-\u03b22. Nat Struct Mol Biol\u20082006; 13: 1135\u201340.","DOI":"10.1038\/nsmb1175"},{"key":"2022061700402376900_B46","doi-asserted-by":"crossref","unstructured":"Davidson L, Pawson AJ, Millar RP, Maudsley S. Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor. J Biol Chem\u20082004; 279: 1980\u201393.","DOI":"10.1074\/jbc.M309827200"},{"key":"2022061700402376900_B47","unstructured":"Liu J, Chen J, Dai Q, Lee RM. Phospholipid scramblase 3 is the mitochondrial target of protein kinase C\u03b4-induced apoptosis. Cancer Res\u20082003; 63: 1153\u20136."},{"key":"2022061700402376900_B48","doi-asserted-by":"crossref","unstructured":"Wang SW, Parhar K, Chiu KJ, et al. Pertussis toxin promotes macrophage survival through inhibition of acid sphingomyelinase and activation of the phosphoinositide 3-kinase\/protein kinase B pathway. Cell Signal\u20082007; 19: 1772\u201383.","DOI":"10.1016\/j.cellsig.2007.04.001"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/15\/6331\/2595204\/6331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/15\/6331\/2595204\/6331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T22:58:59Z","timestamp":1709161139000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/15\/6331\/541016\/Gonadotropin-Releasing-Hormone-Receptor-Levels-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,1]]},"references-count":48,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2008,8,1]]},"published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-0197","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,1]]}}}